Dolby Laboratories Inc. (DLB) Tops Q2 EPS by 16c; Guides Above
Dolby Laboratories Inc. (NYSE: DLB) reported Q2 EPS of $0.91, $0.16 better than the analyst estimate of $0.75. Revenue for the quarter came in at $260.3 million versus the consensus estimate of $253.53 million.
Dolby Laboratories Inc. sees FY2012 EPS of $2.80-$3.04, versus the consensus of $2.57. Dolby Laboratories Inc. sees FY2012 revenue of $910-$960 million, versus the consensus of $942 million.
For earnings history and earnings-related data on Dolby Laboratories Inc. (DLB) click here.
Dolby Laboratories Inc. sees FY2012 EPS of $2.80-$3.04, versus the consensus of $2.57. Dolby Laboratories Inc. sees FY2012 revenue of $910-$960 million, versus the consensus of $942 million.
For earnings history and earnings-related data on Dolby Laboratories Inc. (DLB) click here.